"Altimmune's New Weight-Loss Drug Minimizes Muscle Loss and Mimics Exercise Effects"
Altimmune has developed a new GLP-1 drug, pemvidutide, which helps patients lose 75% fat and only 25% muscle, unlike existing drugs like Ozempic and Mounjaro, which can lead to significant muscle loss. The drug combines a GLP-1 drug with another to mimic the effects of exercise, potentially offering a solution to the issue of muscle loss while on weight-loss medication. Other drugmakers, such as Eli Lilly, are also working on solutions to preserve muscle mass in patients using similar drugs.
